Because the inhibition of Pol γ selectively kills MLH1 deficient cancer cells [3], we tested the effect of four small molecules that came out of our screen, including CR, our top Pol γ inhibitor, on MLH1 deficient colon cancer cell lines. The gene discussed is MLH1; the disease is cancer.